Athira Pharma Inc. (ATHA): Price and Financial Metrics
ATHA Price/Volume Stats
| Current price | $0.64 | 52-week high | $4.30 |
| Prev. close | $0.65 | 52-week low | $0.41 |
| Day low | $0.63 | Volume | 257,600 |
| Day high | $0.66 | Avg. volume | 1,672,120 |
| 50-day MA | $0.52 | Dividend yield | N/A |
| 200-day MA | $2.18 | Market Cap | 24.84M |
ATHA Stock Price Chart Interactive Chart >
Athira Pharma Inc. (ATHA) Company Bio
Athira Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company was founded by Leen Kawas and Joseph Harding in 2011 and is headquartered in Seattle, WA.
ATHA Price Returns
| 1-mo | 20.98% |
| 3-mo | -80.72% |
| 6-mo | -75.76% |
| 1-year | -57.33% |
| 3-year | -95.62% |
| 5-year | N/A |
| YTD | -73.66% |
| 2023 | -23.34% |
| 2022 | -75.67% |
| 2021 | -61.96% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...